title: [Results of treatment with COX-2 inhibitors and lanreotide in a patient with Menetrier's hypertrophic gastropathy].
authors.forename: Vincent
authors.initials: V
authors.lastname: Maunoury
authors.forename: Agnès
authors.initials: A
authors.lastname: Wacrenier
authors.forename: Georgia
authors.initials: G
authors.lastname: Malamut
authors.forename: Pierre
authors.initials: P
authors.lastname: Desreumaux
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000068579:Celecoxib; D005758:Gastritis, Hypertrophic / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D011720:Pyrazoles; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005765:Gastrointestinal Agents; D010456:Peptides, Cyclic; D011720:Pyrazoles; D013449:Sulfonamides; C060347:lanreotide; D013004:Somatostatin; D000068579:Celecoxib